Skip to main content

Table 3 Number and percent of cases with positive expression within different pathohistological entities

From: Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature

PH diagnosis

No of cases

CK 19

HBME 1

Galectin 3

CD 56a

N

%

N

%

N

%

N

%

Colloid adenoma

30

11

36.7 %

1

3.3 %

4

13.3 %

4

86.70 %

Follicular adenoma

27

6

22.2 %

4

14.8 %

11

40.7 %

1

96.30 %

Hurthle cell adenoma

10

6

60.0 %

7

70.0 %

5

50.0 %

1

90.00 %

Hyperplastic adenoma

12

0

0.0 %

0

0.0 %

8

66.7 %

0

100.00 %

Follicular carcinoma

15

5

33.3 %

4

26.7 %

11

73.3 %

4

73.30 %

Hurhle cell carcinoma

20

12

60.0 %

17

85.0 %

17

85.0 %

2

90.00 %

Papillary carcinoma

87

75

86.2 %

66

75.9 %

80

92.0 %

65

25.30 %

  1. aimmunopositivity in >10 % follicular cells